课题基金 / 基金详情

ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM

ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM
细胞色素 P450 3A5 基因型对氟康唑/咪达唑仑的作用
批准号:
7377425
负责人:
PAUL B WATKINS
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

PAUL B WATKINS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to investigate the function of different versions of a gene responsible for producing a particular enzyme, called cytochrome P450 3A5 (CYP3A5). We will study the effect of the different gene versions upon the metabolism of two medications, midazolam and erythromycin. We will also study the influence of the different gene versions upon the effect that the medication fluconazole has upon the metabolism of midazolam and erythromycin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)
ACETAMINOPHEN (TYLENOL?) INDUCED HUMAN LYMPHOCYTE TOXICITY
海外基金